Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 32

Trial Status

Completed2
Terminated1

Role Distribution

Other Roles3

Activity Timeline

Clinical Trials (3)

NCT00003683Phase 2Completed
Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer
Kidney Cancer
StudychairStart date: 1998-03-01
NCT00022191Phase 3Completed
Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Studychair

Research Network

Collaboration Network

11 collaborators·31 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

David C. Smith, MD

University of Michigan Rogel Cancer Center

Moderately Similar
3 trials

Shared therapeutic areas:

Urinary Bladder CancerProstate CancerTransitional Cell Cancer of the Renal Pelvis and Ureter+1 more

Worked with same sponsors:

Central European Cooperative Oncology GroupEuropean Organisation for Research and Treatment of Cancer - EORTC+8 more
Collaborated on 1 trial
Similarity Score44%

Malcolm J. Moore, MD

Princess Margaret Hospital, Canada

Moderately Similar
9 trials

Shared therapeutic areas:

Prostate CancerUrinary Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter+1 more

Worked with same sponsors:

Central European Cooperative Oncology GroupEuropean Organisation for Research and Treatment of Cancer - EORTC+8 more
Collaborated on 1 trial
Similarity Score44%

Joaquim Bellmunt, MD, PhD

Vall d'Hebron University Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Urinary Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterCancer of Urethra

Worked with same sponsors:

Central European Cooperative Oncology GroupEuropean Organisation for Research and Treatment of Cancer - EORTC+8 more
Collaborated on 1 trial
Similarity Score34%

Michael Leahy, MBChB, FRACP, FRCP, FRC Path

Fremantle Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Urinary Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterCancer of Urethra

Worked with same sponsors:

Central European Cooperative Oncology GroupEuropean Organisation for Research and Treatment of Cancer - EORTC+8 more
Collaborated on 1 trial
Similarity Score34%

Christoph Zielinski, MD

Allgemeines Krankenhaus - Universitatskliniken

Moderately Similar
1 trials

Shared therapeutic areas:

Urinary Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterCancer of Urethra

Worked with same sponsors:

Central European Cooperative Oncology GroupEuropean Organisation for Research and Treatment of Cancer - EORTC+8 more
Collaborated on 1 trial
Similarity Score34%

Jose Baselga, MD

Vall d'Hebron University Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Urinary Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterCancer of Urethra

Worked with same sponsors:

Central European Cooperative Oncology GroupEuropean Organisation for Research and Treatment of Cancer - EORTC+8 more
Collaborated on 1 trial
Similarity Score34%

Andreas Boehle, MD

Universitaetsklinikum Schleswig-Holstein - Campus Luebeck

Moderately Similar
1 trials

Shared therapeutic areas:

Urinary Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterCancer of Urethra

Worked with same sponsors:

Central European Cooperative Oncology GroupEuropean Organisation for Research and Treatment of Cancer - EORTC+8 more
Collaborated on 1 trial
Similarity Score34%

Primo N. Lara, MD

University of California, Davis

Moderately Similar
13 trials

Shared therapeutic areas:

Prostate CancerCancer of KidneyUrinary Bladder Cancer+2 more

Worked with same sponsors:

National Cancer Institute (NCI)SWOG Cancer Research Network
Similarity Score30%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Prostate CancerCancer of KidneyCancer of Urethra

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score18%

Chi Fai Ng, MD

Chinese University of Hong Kong

Related
30 trials

Shared therapeutic areas:

Prostate CancerUrinary Bladder CancerCancer of Kidney
Similarity Score18%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00003683Phase 2StudyChair

Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer

Kidney Cancer
Completed
NCT00003682Phase 3StudyChair

Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer

Prostate Cancer
Terminated
NCT00022191Phase 3StudyChair

Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer

Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Completed

All 3 trials loaded